Literature DB >> 21086219

A practical guide to pediatric multiple sclerosis.

P Huppke1, J Gärtner.   

Abstract

During the past 10 years much knowledge has been gained about multiple sclerosis in the pediatric population. This article summarizes the information relevant to the neurologist and pediatric neurologist concerning the diagnosis, differential diagnosis and therapy for pediatric MS. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21086219     DOI： 10.1055/s-0030-1267155

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN： 0174-304X            Impact factor:   1.947


  4 in total

Review 1.  [Interferon-β1b in multiple sclerosis therapy: more than 20 years clinical experience].

Authors:  H-P Hartung; J Haas; M Meergans; F Tracik; S Ortler
Journal:  Nervenarzt       Date:  2013-06       Impact factor: 1.214

2.  Interferon beta-1b in treatment-naïve paediatric patients with relapsing-remitting multiple sclerosis: Two-year results from the BETAPAEDIC study.

Authors:  Jutta Gärtner; Wolfgang Brück; Almuth Weddige; Hannah Hummel; Christiane Norenberg; Jörg-Peter Bugge
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-12-26

3.  Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS.

Authors:  Angelo Ghezzi; Giancarlo Comi; Luigi Maria Grimaldi; Lucia Moiola; Carlo Pozzilli; Simone Fantaccini; Paolo Gallo
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-07-01

4.  Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis.

Authors:  Marie-Christine Reinert; Pascal Benkert; Jens Wuerfel; Zuzanna Michalak; Esther Ruberte; Christian Barro; Peter Huppke; Wiebke Stark; Harald Kropshofer; Davorka Tomic; David Leppert; Jens Kuhle; Wolfgang Brück; Jutta Gärtner
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-05-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.